These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21434595)

  • 21. Description of leprosy classification at baseline among patients enrolled at the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Moura RS; Penna GO; Cardoso LP; de Andrade Pontes MA; Cruz R; de Sá Gonçalves H; Fernandes Penna ML; de Araújo Stefani MM; Bührer-Sékula S
    Am J Trop Med Hyg; 2015 Jun; 92(6):1280-4. PubMed ID: 25940192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, bacteriological and histopathological study of 62 referral relapse cases between Jan 2004 and Dec 2009 at the Foundation for Medical Research, Mumbai.
    Shetty VP; Wakade AV; Ghate SD; Pai VV
    Lepr Rev; 2011 Sep; 82(3):235-43. PubMed ID: 22125931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):558-68. PubMed ID: 1802938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
    Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
    Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deformity incidence in leprosy patients treated with multidrug therapy.
    Rao PS; Subramanian M; Subramanian G
    Indian J Lepr; 1994; 66(4):449-54. PubMed ID: 7714354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relapse of leprosy after multidrug therapy.
    Dasananjali K
    J Med Assoc Thai; 1996 Oct; 79(10):635-9. PubMed ID: 8996998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
    Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics of leprosy reactions in paucibacillary and multibacillary individuals attended at two reference centers in Recife, Pernambuco].
    Teixeira MA; Silveira VM; França ER
    Rev Soc Bras Med Trop; 2010; 43(3):287-92. PubMed ID: 20563498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I; Dogra S; Kumar B; Radotra BD
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular hypotension and hypotony in multibacillary leprosy patients; at diagnosis, during and after completion of multidrug therapy.
    Daniel E; Rao PS; Ffytche TJ; Courtright P
    Indian J Lepr; 2010; 82(4):181-8. PubMed ID: 21434594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical analysis of multibacillary leprosy patients after 1-year fixed World Health Organization recommended multidrug therapy at Yangon General Hospital, Myanmar.
    Kyaw K; Tsoh TM; Swe SY; Nagaoka Y; Takezaki S; Suzuki K; Ishii N
    J Dermatol; 2008 May; 35(5):264-9. PubMed ID: 18477225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary results of clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): reactions frequency in multibacillary patients.
    Penna ML; Buhrer-Sékula S; Pontes MA; Cruz R; Gonçalves Hde S; Penna GO
    Lepr Rev; 2012 Sep; 83(3):308-19. PubMed ID: 23356032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multi-centre study on quality of routine data collection on relapses.
    Deepak S; Gazzoli G
    Lepr Rev; 2012 Dec; 83(4):340-3. PubMed ID: 23614251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed-duration multidrug therapy in multibacillary leprosy.
    Li HY; Hu LF; Wu PW; Luo JS; Liu XM
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of lepromatous granuloma in clinically cured cases of leprosy.
    Desikan P; Desikan KV
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):417-21. PubMed ID: 7594925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, histopathological and bacteriological study of 52 referral MB cases relapsing after MDT.
    Shetty VP; Wakade AV; Ghate SD; Pai VV; Ganapati RR; Antia NH
    Lepr Rev; 2005 Sep; 76(3):241-52. PubMed ID: 16248211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
    Lazo-Porras M; Prutsky GJ; Barrionuevo P; Tapia JC; Ugarte-Gil C; Ponce OJ; Acuña-Villaorduña A; Domecq JP; De la Cruz-Luque C; Prokop LJ; Málaga G
    BMC Infect Dis; 2020 Jan; 20(1):62. PubMed ID: 31959113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.